Company Encyclopedia
View More
name
TONG REN TANG
01666.HK
Tong Ren Tang Technologies Co. Ltd., together with its subsidiaries, produces and distributes Chinese medicine products in Mainland China and Hong Kong. It operates through The Company; Tong Ren Tang Chinese Medicine; and Others segments. The company also develops, cultivates, processes, and purchases Chinese medicinal raw materials; retails and wholesales Chinese medicine products and healthcare products; and offers ointments, healthcare products, tea drinks, food, foot care products, biological products, western medicine, and cosmetics.
1.412 T
01666.HKMarket value -Rank by Market Cap -/-

Financial Score

27/12/2025 Update
C
PharmaceuticalsIndustry
Industry Ranking27/48
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE6.00%C
    • Profit Margin6.21%B
    • Gross Margin38.16%B
  • Growth ScoreC
    • Revenue YoY1.18%C
    • Net Profit YoY-33.56%D
    • Total Assets YoY3.66%C
    • Net Assets YoY5.63%B
  • Cash ScoreB
    • Cash Flow Margin1609.43%B
    • OCF YoY1.18%C
  • Operating ScoreC
    • Turnover0.48C
  • Debt ScoreB
    • Gearing Ratio29.78%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Tong Ren Tang Technologies Signs Three-Year Land Use Lease with Tong Ren Tang Holdings

    Tong Ren Tang Technologies Co. Ltd. has renewed a three-year land use lease agreement with Tong Ren Tang Holdings for land in Beijing, effective from October 6, 2025, to October 5, 2028. The transaction complies with Hong Kong Listing Rules but doesn't require independent shareholders' approval. The news was generated by Public Technologies using AI and published by Tong Ren Tang Technologies via the Hong Kong Stock Exchange.

    Reuters·
    HK
    01666
    +1.36%
    Reuters·
    HK
    01666
    +1.36%

    Tong Ren Tang Technologies Appoints New Company Secretary and Board Secretary

    Tong Ren Tang Technologies Co. Ltd. has appointed Ms. Ma Wing Yee as company secretary, authorised representative, and process agent, and Mr. Han Guan Zhao as secretary of the Board, effective from November 28, 2025. Mr. Li Yijun has resigned from his roles. This announcement was made via the Hong Kong Stock Exchange's Issuer Information Service.

    Reuters·
    HK
    01666
    +1.36%
    Reuters·
    HK
    01666
    +1.36%

    Tong Ren Tang Technologies Co. Ltd. Announces Date for Extraordinary General Meeting

    Tong Ren Tang Technologies Co. Ltd. has announced an extraordinary general meeting on 30 December 2025 in Beijing, China. Shareholders will vote on resolutions as per the meeting notice. The original content was published via the Issuer Information Service of the Hong Kong Stock Exchange on 28 November 2025.

    Reuters·
    HK
    01666
    +1.36%
    Reuters·
    HK
    01666
    +1.36%

    Tong Ren Tang Technologies Proposes Du Xin as New Non-Executive Director

    Tong Ren Tang Technologies Co. Ltd. announced the resignation of Mr. Chen Fei as non-executive Director due to work adjustments. The Board proposed Ms. Du Xin as the new non-executive Director, pending shareholder approval at the upcoming general meeting.

    Reuters·
    HK
    01666
    +1.36%
    Reuters·
    HK
    01666
    +1.36%

    Tong Ren Tang released its performance for the first three quarters, with a net profit attributable to the parent company of 1.178 billion yuan, a decrease of 12.78%

    According to the Zhitong Finance APP, TONGREN TANG released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 13.308 billion yuan, a year-on-year decrease of 3.70%. The net profit attributable to shareholders of the listed company was 1.178 billion yuan, a year-on-year decrease of 12.78%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.163 billion yuan, a year-on-year decrease of 11.95%. The basic earnings per share were 0.859 yuan

    Zhitong·
    HK
    03613
    +0.12%
    SH
    600085
    +1.26%
    HK
    01666
    +1.36%
    Zhitong·
    HK
    03613
    +0.12%
    SH
    600085
    +1.26%
    HK
    01666
    +1.36%
    © 2025 Longbridge｜Disclaimer